Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cardillo

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2015
Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan)Robert M Sharkey, William J McBride, Thomas M Cardillo, et al.
Neural Regeneration Research|September 24, 2021
Antipsychotics preserve telomere length in peripheral blood mononuclear cells after acute oxidative stress injuryGabriel B Polho, Giancarlo M Cardillo, Daniel S Kerr, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Enhanced Anti-Babesia Efficacy of Buparvaquone and Imidocarb When Combined with ELQ-316 In Vitro Culture of <i>Babesia bigemina</i>Natalia M Cardillo, Nicolas F Villarino, Paul A Lacy, et al.
Blood|October 23, 2008
Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibodyDavid M Goldenberg, Edmund A Rossi, Rhona Stein, et al.
Bioconjugate Chemistry|April 28, 2015
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other CancersThomas M Cardillo, Serengulam V Govindan, Robert M Sharkey, et al.
The American Naturalist|May 5, 2007
The fast-slow continuum in mammalian life history: an empirical reevaluationJ Bielby, G M Mace, O R P Bininda-Emonds, et al.
Pharmaceutics|November 27, 2024
The Combination of Buparvaquone and ELQ316 Exhibit a Stronger Effect than ELQ316 and Imidocarb Against <i>Babesia bovis</i> In VitroNatalia M Cardillo, Nicolas F Villarino, Paul A Lacy, et al.
Human Immunology|August 6, 2021
Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian populationN Sacchi, F Ciceri, F Bonifazi, et al.
Transplantation Proceedings|October 20, 2019
Analysis of the Trend Over Time of High-Urgency Liver Transplantation Requests in Italy in the 4-Year Period 2014-2017S Trapani, F Puoti, V Morabito, et al.
BMC Cancer|July 10, 2010
Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mousePaola Aulino, Emanuele Berardi, Veronica M Cardillo, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2015
Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan)Robert M Sharkey, William J McBride, Thomas M Cardillo, et al.
Neural Regeneration Research|September 24, 2021
Antipsychotics preserve telomere length in peripheral blood mononuclear cells after acute oxidative stress injuryGabriel B Polho, Giancarlo M Cardillo, Daniel S Kerr, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Enhanced Anti-Babesia Efficacy of Buparvaquone and Imidocarb When Combined with ELQ-316 In Vitro Culture of <i>Babesia bigemina</i>Natalia M Cardillo, Nicolas F Villarino, Paul A Lacy, et al.
Blood|October 23, 2008
Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibodyDavid M Goldenberg, Edmund A Rossi, Rhona Stein, et al.
Bioconjugate Chemistry|April 28, 2015
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other CancersThomas M Cardillo, Serengulam V Govindan, Robert M Sharkey, et al.
The American Naturalist|May 5, 2007
The fast-slow continuum in mammalian life history: an empirical reevaluationJ Bielby, G M Mace, O R P Bininda-Emonds, et al.
Pharmaceutics|November 27, 2024
The Combination of Buparvaquone and ELQ316 Exhibit a Stronger Effect than ELQ316 and Imidocarb Against <i>Babesia bovis</i> In VitroNatalia M Cardillo, Nicolas F Villarino, Paul A Lacy, et al.
Human Immunology|August 6, 2021
Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian populationN Sacchi, F Ciceri, F Bonifazi, et al.
Transplantation Proceedings|October 20, 2019
Analysis of the Trend Over Time of High-Urgency Liver Transplantation Requests in Italy in the 4-Year Period 2014-2017S Trapani, F Puoti, V Morabito, et al.
BMC Cancer|July 10, 2010
Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mousePaola Aulino, Emanuele Berardi, Veronica M Cardillo, et al.
Pageof 14